Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

Upcoming preclinical webinars

Latest preclinical blogs

Meet our experts at the following events

Conference

Pharmacometrics Approach Group in Japan 2026​

November 13, 2026
Conference

American College of Toxicology 2026 Annual Meeting

November 15 - 18, 2026 – San Antonio, TX – Booth 719
Conference

JSSX 2026 in Japan

November 17 - 19, 2026

All preclinical resources

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

What is new in Phoenix 8.9?

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Bridging Oncology and Autoimmune Disease: Using QSP to Select T-Cell Engager Doses by CRS Risk and Efficacy

Biologics, Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - QSP, Poster

2nd Model-Informed Drug Development Summit

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

Strategy Starts at Discovery: Using QSP to Choose the Right Indication, the Right Asset, and the Right Path to First-in-Human

Biologics, Certara Services, Drug Development, Modeling and Simulation - QSP, On-Demand Webinar

Drug-Drug Interaction (DDI) Calculator

Drug Development, Drug-Drug Interactions (DDI), Model Informed Drug Development, Fact Sheet

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development

Modeling and Simulation - QSP, Publication

Securing Pimicotinib Approval: How Abbisko Therapeutics Successfully Completed its NMPA and FDA Submissions with Pinnacle 21 Enterprise

Certara Products - Pinnacle 21, Case Study

Get the Presentation: Building Investor-Ready Biotech Strategies

Drug Development, Drug Development Support, Guide

Enable AI to Access your PK Data: What’s New in Integral 7.1

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs

Certara Products - Certara IQ, Certara Products - Simcyp, Infectious Disease, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Oncology/Hematology, Publication

Modeling effective doses of therapeutic antibodies targeting clustered surface receptors

Biologics, Certara Services, Immuno-oncology, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.